Quantitative assessment of skeletal muscle degeneration in patients with myotonic dystrophy type 1 using MRI

Journal of Magnetic Resonance Imaging

Volumn 35, Issue 3, 2012, Pages 678-685

  Hiba, Bassem ^a,b   Richard, Nathalie ^c   Hébert, Luc J ^d,e   Coté, Chantal ^f   Nejjari, Mimoun ^g   Vial, Christoph ^h   Bouhour, Françoise ^h   Puymirat, Jack ^f   Janier, Marc ^a,g  

^a UNIVERSITÉ LYON 1   (France)

^b UNIVERSITÉ DE BORDEAUX   (France)

^c UNIVERSITÉ DE LYON   (France)

^d UNIVERSITÉ LAVAL   (Canada)

^e National Defense of Canada   (Canada)

^f LAVAL UNIVERSITY   (Canada)

^g EDOUARD HERRIOT HOSPITAL   (France)

^h HÔPITAL NEUROLOGIQUE   (France)

Author keywords

fat infiltration; muscle segmentation; myotonic dystrophy type 1; quantitative MRI; therapy charting

Indexed keywords

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE COURSE; DYNAMOMETRY; EDEMA; FEMALE; HUMAN; HUMAN TISSUE; MALE; MUSCLE ATROPHY; MUSCLE STRENGTH; MUSCLE TISSUE; MYOTONIC DYSTROPHY; NUCLEAR MAGNETIC RESONANCE IMAGING; OBSERVER VARIATION; OUTCOME ASSESSMENT; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RELAXATION TIME; TIBIALIS ANTERIOR MUSCLE; TORQUE;

ADULT; ANKLE JOINT; BIOLOGICAL MARKERS; FEMALE; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MUSCLE STRENGTH; MUSCLE, SKELETAL; MUSCULAR ATROPHY; MYOTONIC DYSTROPHY; REPRODUCIBILITY OF RESULTS; STATISTICS, NONPARAMETRIC;

EID: 84857070597     PISSN: 10531807     EISSN: 15222586     Source Type: Journal    
DOI: 10.1002/jmri.22849     Document Type: Article

References (29)

1. Shaw DJ, Harper PS,. Myotonic dystrophy: developments in molecular genetics. Br Med Bull 1989; 45: 745-759. (Pubitemid 19189378)
2. Norman AM, Floyd JL, Meredith AL, Harper PS,. Presymptomatic detection and prenatal diagnosis for myotonic dystrophy by means of linked DNA markers. J Med Genet 1989; 26: 750-754. (Pubitemid 20008537)
3. Lunt PW, Compston DA, Harper PS,. Estimation of age dependent penetrance in facioscapulohumeral muscular dystrophy by minimising ascertainment bias. J Med Genet 1989; 26: 755-760. (Pubitemid 20008538)
4. Bushby K, Lochmuller H, Lynn S, Straub V,. Interventions for muscular dystrophy: molecular medicines entering the clinic. Lancet 2009; 374: 1849-1856.
5. Hébert LJ,. Évaluation de la force musculaire et dynamomètres manuels: Concepts de base et applications pratiques. ISBN 2-9809219-0-4. Québec: Bibliothèque nationale du Québec et Bibliothèque et Archives Canada; 2006. p 276.
6. Esformes JI, Narici MV, Maganaris CN,. Measurement of human muscle volume using ultrasonography. Eur J Appl Physiol 2002; 87: 90-92. (Pubitemid 41399037)
7. Maurits NM, Bollen AE, Windhausen A, De Jager AE, Van Der Hoeven JH,. Muscle ultrasound analysis: normal values and differentiation between myopathies and neuropathies. Ultrasound Med Biol 2003; 29: 215-225. (Pubitemid 36349280)
8. Weller R, Pfau T, Ferrari M, Griffith R, Bradford T, Wilson A,. The determination of muscle volume with a freehand 3D ultrasonography system. Ultrasound Med Biol 2007; 33: 402-407. (Pubitemid 46275177)
9. Maughan RJ, Watson JS, Weir J,. Strength and cross-sectional area of human skeletal muscle. J Physiol 1983; 338: 37-49. (Pubitemid 13099474)
10. Liu M, Chino N, Ishihara T,. Muscle damage progression in Duchenne muscular dystrophy evaluated by a new quantitative computed tomography method. Arch Phys Med Rehabil 1993; 74: 507-514. (Pubitemid 23141400)
11. Kornblum C, Lutterbey G, Bogdanow M, et al. Distinct neuromuscular phenotypes in myotonic dystrophy types 1 and 2: a whole body highfield MRI study. J Neurol 2006; 253: 753-761. (Pubitemid 43980147)
12. Phoenix J, Betal D, Roberts N, Helliwell TR, Edwards RH,. Objective quantification of muscle and fat in human dystrophic muscle by magnetic resonance image analysis. Muscle Nerve 1996; 19: 302-310. (Pubitemid 26069360)
13. Coté C, Hiba B, Hebert LJ, et al. MRI of tibialis anterior skeletal muscle in myotonic dystrophy type 1. Can J Neurol Sci 2011; 38: 112-118.
14. Sookhoo S, Mackinnon I, Bushby K, Chinnery PF, Birchall D,. MRI for the demonstration of subclinical muscle involvement in muscular dystrophy. Clin Radiol 2007; 62: 160-165. (Pubitemid 46024209)
15. Fischer D, Walter MC, Kesper K, et al. Diagnostic value of muscle MRI in differentiating LGMD2I from other LGMDs. J Neurol 2005; 252: 538-547. (Pubitemid 40768169)
16. Bryan WW, Reisch JS, McDonald G, Herbelin LL, Barohn RJ, Fleckenstein JL,. Magnetic resonance imaging of muscle in amyotrophic lateral sclerosis. Neurology 1998; 51: 110-113. (Pubitemid 28345368)
17. Wren TA, Bluml S, Tseng-Ong L, Gilsanz V,. Three-point technique of fat quantification of muscle tissue as a marker of disease progression in Duchenne muscular dystrophy: preliminary study. AJR Am J Roentgenol 2008; 190: W8-W12.
18. Pfirrmann CW, Schmid MR, Zanetti M, Jost B, Gerber C, Hodler J,. Assessment of fat content in supraspinatus muscle with proton MR spectroscopy in asymptomatic volunteers and patients with supraspinatus tendon lesions. Radiology 2004; 232: 709-715. (Pubitemid 39100252)
19. Sled JG, Zijdenbos AP, Evans AC,. A non-parametric method for automatic correction of intensity non-uniformity in MRI data. IEEE Trans Med Imaging 1998; 17: 87-97. (Pubitemid 128742012)
20. Celeux G, Forbes F, Peyrard N,. EM procedures using mean filed-like approximations for Markov model-based image segmentation. Pattern Recognit 2003; 36: 131-144.
21. Bezdek JC, Hall LO, Clarke LP,. Review of MR image segmentation techniques using pattern recognition. Med Phys 1993; 20: 1033-1048. (Pubitemid 23249849)
22. Mathieu J, Boivin H, Richards CL,. Quantitative motor assessment in myotonic dystrophy. Can J Neurol Sci 2003; 30: 129-136. (Pubitemid 36717995)
23. Hebert LJ, Remec JF, Saulnier J, Vial C, Puymirat J,. The use of muscle strength assessed with handheld dynamometers as a non-invasive biological marker in myotonic dystrophy type 1 patients: a multicenter study. BMC Musculoskelet Disord 2010; 11: 72.
24. Dixon WT,. Simple proton spectroscopic imaging. Radiology 1984; 153: 189-194. (Pubitemid 14043406)
25. Guclu CC, Kovanlikaya I, Desai C, Gilsanz V, Becerra R, Kovanlikaya A,. Lipid percentage measurements using three-point Dixon method. In: Proceedings of the 12th Scientific Meeting and Exhibition of ISMRM, Kyoto, Japan, 2004. (abstract 497).
26. Kovanlikaya A, Guclu C, Desai C, Becerra R, Gilsanz V,. Fat quantification using three-point Dixon technique: in vitro validation. Acad Radiol 2005; 12: 636-639. (Pubitemid 40603691)
27. Kan HE, Scheenen TW, Wohlgemuth M, et al. Quantitative MR imaging of individual muscle involvement in facioscapulohumeral muscular dystrophy. Neuromuscul Disord 2009; 19: 357-362.
28. Stramare R, Beltrame V, Dal Borgo R, et al. MRI in the assessment of muscular pathology: a comparison between limb-girdle muscular dystrophies, hyaline body myopathies and myotonic dystrophies. Radiol Med 2010; 115: 585-599.
29. Kovanlikaya A, Mittelman SD, Ward A, Geffner ME, Dorey F, Gilsanz V,. Obesity and fat quantification in lean tissues using three-point Dixon MR imaging. Pediatr Radiol 2005; 35: 601-607. (Pubitemid 40724032)